Interview with Jacek Barlinski, Country Manager, Nycomed Poland
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
Address: ul. Zbąszyńska 3 91-342 Łódź
,Poland
Tel: +48 (42) 61 33 444
Web: http://www.pelion.eu/s/60
PGF is the leading company working in healthcare business, concentrating on drug and medical products supply. It derives from 1990 when Mr. Jacek Szwajcowski established the pharmaceutical wholesale – MEDICINES. It was designed to help to transform polish pharma-services into a modern, efficient and quality-driven system.
When wholesale trade in pharmaceuticals was deregulated, it became clear that top market standards could only be achieved by a large organisation with nationwide coverage. Thanks to a series of mergers and acquisitions, PGF has become such a company.
As the most popular domestic wholesale distributor of pharmaceuticals, we have optimised our nationwide sales network. We offer 18 thousand different types of pharmaceutical items from every single existing pharmacological group. We don’t just stop at pharmaceuticals. We sell medical equipment, herbal preparations, and cosmetics. Pharmaceutical sales is PGF’s main revenue (more than 90%), and its share is growing continually. At present, our objective is to harness the opportunities emerging in the ever expanding pharmaceuticals market in Poland.
PGF, the decision making headquarters, manages contact with drug makers and distribution within the PGF group through two branches, in Łódź and Katowice. Thanks to our centralised procurement and given the scale of the Group’s operations, we have been able to secure advantageous supply agreements, which in turn enables us to offer the most attractive service to our customers.
The pharmaceutical distribution is carried out by our subsidiary companies located throughout the whole country. This helps us to maintain a strong position on all the local markets.
PGF also distributes pharmaceuticals to hospitals. Our excellent range on offer and efficient customer service has made us the unquestionable market leader in this segment, supplying one in every three pharmaceutical items used for in-patient health care.
PGF’s strong market position is beneficial to smaller companies also active in pharmaceutical distribution. With annual revenues of more than bilion, PGF as the largest private company established in post-communism Poland ranks among the 100 biggest Central&Eastern Europe companys.
The strategic objective of the Group is to become the leader in Central and Eastern Europe, by consolidating the retail markets in countries of the region. The Group operates in the healthcare sector in Poland and Lithuania. Its services cover all market segments (wholesale, retail sale and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers.
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone…
You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was…
For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to…
Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in…
With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market,…
Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent legislation. Nevertheless, Poland has changed and…
The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the country? The group has been present in…
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
See our Cookie Privacy Policy Here